Cargando…

Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition

In the last decade, machine learning and artificial intelligence applications have received a significant boost in performance and attention in both academic research and industry. The success behind most of the recent state-of-the-art methods can be attributed to the latest developments in deep lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschka, Sebastian, Kaufman, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457393/
https://www.ncbi.nlm.nih.gov/pubmed/32645448
http://dx.doi.org/10.1016/j.ymeth.2020.06.016
_version_ 1784571085319045120
author Raschka, Sebastian
Kaufman, Benjamin
author_facet Raschka, Sebastian
Kaufman, Benjamin
author_sort Raschka, Sebastian
collection PubMed
description In the last decade, machine learning and artificial intelligence applications have received a significant boost in performance and attention in both academic research and industry. The success behind most of the recent state-of-the-art methods can be attributed to the latest developments in deep learning. When applied to various scientific domains that are concerned with the processing of non-tabular data, for example, image or text, deep learning has been shown to outperform not only conventional machine learning but also highly specialized tools developed by domain experts. This review aims to summarize AI-based research for GPCR bioactive ligand discovery with a particular focus on the most recent achievements and research trends. To make this article accessible to a broad audience of computational scientists, we provide instructive explanations of the underlying methodology, including overviews of the most commonly used deep learning architectures and feature representations of molecular data. We highlight the latest AI-based research that has led to the successful discovery of GPCR bioactive ligands. However, an equal focus of this review is on the discussion of machine learning-based technology that has been applied to ligand discovery in general and has the potential to pave the way for successful GPCR bioactive ligand discovery in the future. This review concludes with a brief outlook highlighting the recent research trends in deep learning, such as active learning and semi-supervised learning, which have great potential for advancing bioactive ligand discovery.
format Online
Article
Text
id pubmed-8457393
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-84573932021-09-22 Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition Raschka, Sebastian Kaufman, Benjamin Methods Article In the last decade, machine learning and artificial intelligence applications have received a significant boost in performance and attention in both academic research and industry. The success behind most of the recent state-of-the-art methods can be attributed to the latest developments in deep learning. When applied to various scientific domains that are concerned with the processing of non-tabular data, for example, image or text, deep learning has been shown to outperform not only conventional machine learning but also highly specialized tools developed by domain experts. This review aims to summarize AI-based research for GPCR bioactive ligand discovery with a particular focus on the most recent achievements and research trends. To make this article accessible to a broad audience of computational scientists, we provide instructive explanations of the underlying methodology, including overviews of the most commonly used deep learning architectures and feature representations of molecular data. We highlight the latest AI-based research that has led to the successful discovery of GPCR bioactive ligands. However, an equal focus of this review is on the discussion of machine learning-based technology that has been applied to ligand discovery in general and has the potential to pave the way for successful GPCR bioactive ligand discovery in the future. This review concludes with a brief outlook highlighting the recent research trends in deep learning, such as active learning and semi-supervised learning, which have great potential for advancing bioactive ligand discovery. 2020-07-06 2020-08-01 /pmc/articles/PMC8457393/ /pubmed/32645448 http://dx.doi.org/10.1016/j.ymeth.2020.06.016 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Raschka, Sebastian
Kaufman, Benjamin
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title_full Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title_fullStr Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title_full_unstemmed Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title_short Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
title_sort machine learning and ai-based approaches for bioactive ligand discovery and gpcr-ligand recognition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457393/
https://www.ncbi.nlm.nih.gov/pubmed/32645448
http://dx.doi.org/10.1016/j.ymeth.2020.06.016
work_keys_str_mv AT raschkasebastian machinelearningandaibasedapproachesforbioactiveliganddiscoveryandgpcrligandrecognition
AT kaufmanbenjamin machinelearningandaibasedapproachesforbioactiveliganddiscoveryandgpcrligandrecognition